Claim verdict
Tissue repair
“BPC-157 heals tendons in humans.”
This verdict applies to the exact claim above. It is not a verdict on the compound overall, a safety guarantee, or a recommendation to use it.
Registry verdict
Unsupported as stated — the human trials simply don't exist.
Why this verdict
- The tendon-healing story comes almost entirely from rodent models (Level 2).
- No adequately powered published randomised controlled trial in humans supports it.
- 'Unsupported' means we don't know it works — not that we know it fails. Those are different claims and the difference matters.
Claim evidence map
Sources are mapped to this exact claim. Appearance here does not mean every source supports it.
- Evidence gapclinical trial registryClinicalTrials.gov — BPC-HAMSTR Phase 2 trial in acute Grade II hamstring strain (NCT07437547) NCT: NCT07437547
A registered Phase 2 trial shows that the question is being tested; no posted result demonstrates tendon or muscle healing benefit in humans.
- Supports verdictregulatory labelFDA — BPC-157 briefing material prepared for the July 2026 Pharmacy Compounding Advisory Committee
Regulatory evidence review supports the Registry's distinction between extensive preclinical claims and the absence of dependable controlled human efficacy evidence.